Results 191 to 200 of about 53,894 (217)

Neurochemical Endpoints to Inform Early‐Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers   +19 more
wiley   +1 more source

Safety evaluation of an extension of use of a food enzyme containing bacillolysin and subtilisin activities from the non-genetically modified <i>Bacillus amyloliquefaciens</i> strain AR-383. [PDF]

open access: yesEFSA J
EFSA Panel on Food Enzymes (FEZ)   +15 more
europepmc   +1 more source

Genetically modified food versus knowledge and fear: A Noumenic approach for consumer behaviour

Food Research International, 2018
Flavio Boccia   +2 more
exaly  

Home - About - Disclaimer - Privacy